Insights into the Pathogenesis of Pulmonary Fibrosis from Genetic Diseases
Overview
Molecular Biology
Authors
Affiliations
Pulmonary fibrosis is a disease process associated with significant morbidity and mortality, with limited therapeutic options owing to an incomplete understanding of the underlying pathophysiology. Mechanisms driving the fibrotic cascade have been elucidated through studies of rare and common variants in surfactant-related and telomere-related genes in familial and sporadic forms of pulmonary fibrosis, as well as in multisystem Mendelian genetic disorders that present with pulmonary fibrosis. In this translational review, we outline insights into the pathophysiology of pulmonary fibrosis derived from genetic forms of the disease, with a focus on model systems, shared cellular and molecular mechanisms, and potential targets for therapy.
Pezet M, Torres J, Thimraj T, Matkovic I, Schrode N, Murray J Nat Biotechnol. 2025; .
PMID: 39994483 DOI: 10.1038/s41587-025-02569-0.
Engraftment of wild-type alveolar type II epithelial cells in surfactant protein C deficient mice.
Predella C, Lapsley L, Ni K, Murray J, Liu H, Motelow J Res Sq. 2024; .
PMID: 39315275 PMC: 11419168. DOI: 10.21203/rs.3.rs-4673915/v1.
Biomechanical Properties and Cellular Responses in Pulmonary Fibrosis.
He A, He L, Chen T, Li X, Cao C Bioengineering (Basel). 2024; 11(8).
PMID: 39199705 PMC: 11351367. DOI: 10.3390/bioengineering11080747.
Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis.
Desroziers T, Prevot G, Coulomb A, Nau V, Dastot-Le Moal F, Duquesnoy P Eur J Hum Genet. 2023; 31(9):1083-1087.
PMID: 37380697 PMC: 10474257. DOI: 10.1038/s41431-023-01413-w.
Defining the Genetic Landscape of Idiopathic Pulmonary Fibrosis: Role of Common and Rare Variants.
Moss B, Rosas I Am J Respir Crit Care Med. 2023; 207(9):1118-1120.
PMID: 36796091 PMC: 10161759. DOI: 10.1164/rccm.202301-0177ED.